Coronavirus disease 2019 (COVID-19): angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and cardiovascular disease

Med J Aust. 2020 Jun;212(11):502-503.e1. doi: 10.5694/mja2.50622. Epub 2020 May 21.
No abstract available

Keywords: COVID-1; Hypertension; Infectious diseases; Respiratory tract infections.

MeSH terms

  • Angiotensin Receptor Antagonists / adverse effects*
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects*
  • Betacoronavirus / drug effects*
  • COVID-19
  • Cardiovascular Diseases / drug therapy*
  • Coronavirus Infections / complications*
  • Coronavirus Infections / virology
  • Drug-Related Side Effects and Adverse Reactions / virology*
  • Humans
  • Pandemics
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / virology
  • SARS-CoV-2

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors